30 http://www.imeronline.com/podcast/ en-us Institute for Medical Education and Research Institute for Medical Education and Research Institute for Medical Education and Research podcast@imeronline.com podcast@imeronline.com http://www.imeronline.com/podcast/itunes300x300.jpg The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guid clean IMER Medical Education Oncology Nursing Introduction Institute for Medical Education and Research 00:05:49 http://www.imeronline.com/podcast/media/120_renal_intro.mp3 Thu, 28 Jun 2007 16:18:48 -0400 Thu, 19 Jul 2007 17:04:46 -0400 Targeted therapies are showing promise in the treatment of advanced RCC, for which treatment options are limited. In this educational program, the rationale for targeting cellular signaling pathways will be discussed, and clinical data on the use of targeted agents for the treatment of advanced RCC will be presented. Strategies for managing side effects and ensuring safe administration of targeted agents will be emphasized. imer, renal cell, carcinoma, cancer, treatment, educational Episode 1 Institute for Medical Education and Research 00:29:23 http://www.imeronline.com/podcast/media/120_renal_motzer.mp3 Wed, 11 Jul 2007 11:23:25 -0400 Thu, 19 Jul 2007 17:04:57 -0400 Targeted therapies are showing promise in the treatment of advanced RCC, for which treatment options are limited. In this educational program, the rationale for targeting cellular signaling pathways will be discussed, and clinical data on the use of targeted agents for the treatment of advanced RCC will be presented. Strategies for managing side effects and ensuring safe administration of targeted agents will be emphasized. IMER, renal cell, carcinoma, cancer, treatment, educational Episode 2 Institute for Medical Education and Research 00:17:33 http://www.imeronline.com/podcast/media/120_renal_wood.mp3 Wed, 11 Jul 2007 11:24:32 -0400 Thu, 19 Jul 2007 17:05:10 -0400 Targeted therapies are showing promise in the treatment of advanced RCC, for which treatment options are limited. In this educational program, the rationale for targeting cellular signaling pathways will be discussed, and clinical data on the use of targeted agents for the treatment of advanced RCC will be presented. Strategies for managing side effects and ensuring safe administration of targeted agents will be emphasized. IMER, renal cell, carcinoma, cancer, treatment, educational Episode 3 Institute for Medical Education and Research 00:10:01 http://www.imeronline.com/podcast/media/120_renal_fisher.mp3 Wed, 11 Jul 2007 11:25:23 -0400 Thu, 19 Jul 2007 17:05:23 -0400 Targeted therapies are showing promise in the treatment of advanced RCC, for which treatment options are limited. In this educational program, the rationale for targeting cellular signaling pathways will be discussed, and clinical data on the use of targeted agents for the treatment of advanced RCC will be presented. Strategies for managing side effects and ensuring safe administration of targeted agents will be emphasized. IMER, renal cell, carcinoma, cancer, treatment, educational Episode 4 Institute for Medical Education and Research 00:18:54 http://www.imeronline.com/podcast/media/120_renal_qanda.mp3 Wed, 11 Jul 2007 11:26:52 -0400 Thu, 19 Jul 2007 17:05:35 -0400 Targeted therapies are showing promise in the treatment of advanced RCC, for which treatment options are limited. In this educational program, the rationale for targeting cellular signaling pathways will be discussed, and clinical data on the use of targeted agents for the treatment of advanced RCC will be presented. Strategies for managing side effects and ensuring safe administration of targeted agents will be emphasized. IMER, renal cell, carcinoma, cancer, treatment, educational Episode 1 Institute for Medical Education and Research 00:29:37 http://www.imeronline.com/podcast/media/208_ep_1.mp4 Wed, 24 Oct 2007 10:43:50 -0400 Wed, 24 Oct 2007 10:43:50 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. imer, renal cell, tumor, cancer, treatment, multitargeted agents, educational, oncology Episode 2 Institute for Medical Education and Research 00:33:18 http://www.imeronline.com/podcast/media/208_ep_2.mp4 Wed, 24 Oct 2007 10:45:28 -0400 Wed, 24 Oct 2007 10:45:28 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. imer, renal cell, tumor, cancer, treatment, multitargeted agents, educational, oncology Episode 3 Institute for Medical Education and Research 00:32:46 http://www.imeronline.com/podcast/media/208_ep_3.mp4 Wed, 24 Oct 2007 10:47:00 -0400 Wed, 24 Oct 2007 10:47:00 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. Imer, renal cell, tumor, cancer, treatment, multitargeted agents, educational, oncology Episode 4 Institute for Medical Education and Research 00:16:45 http://www.imeronline.com/podcast/media/208_ep_4.mp4 Wed, 24 Oct 2007 11:05:53 -0400 Wed, 24 Oct 2007 11:05:53 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. Imer, renal cell, tumor, cancer, treatment, multitargeted agents, educational, oncology Episode 1 Institute for Medical Education and Research 00:06:43 http://www.imeronline.com/podcast/media/220_1.m4v Fri, 12 Oct 2007 13:53:34 -0400 Fri, 12 Oct 2007 14:08:32 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 2 Institute for Medical Education and Research 00:09:21 http://www.imeronline.com/podcast/media/220_2.m4v Fri, 12 Oct 2007 13:56:46 -0400 Fri, 12 Oct 2007 13:56:46 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, anemia, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 3 Institute for Medical Education and Research 00:13:23 http://www.imeronline.com/podcast/media/220_3.m4v Fri, 12 Oct 2007 13:59:33 -0400 Fri, 12 Oct 2007 13:59:33 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, anemia, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 4 Institute for Medical Education and Research 00:13:30 http://www.imeronline.com/podcast/media/220_4.m4v Fri, 12 Oct 2007 14:08:07 -0400 Fri, 12 Oct 2007 14:08:07 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. imer, renal cell, carcinoma, cancer, treatment, educational, oncology Episode 5 Institute for Medical Education and Research 00:24:09 http://www.imeronline.com/podcast/media/220_5.m4v Fri, 12 Oct 2007 14:19:43 -0400 Fri, 12 Oct 2007 14:19:43 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 6 Institute for Medical Education and Research 00:05:54 http://www.imeronline.com/podcast/media/220_6.m4v Fri, 12 Oct 2007 14:21:59 -0400 Fri, 12 Oct 2007 14:21:59 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 7 Institute for Medical Education and Research 00:03:57 http://www.imeronline.com/podcast/media/220_7.m4v Fri, 12 Oct 2007 14:27:46 -0400 Fri, 12 Oct 2007 14:27:46 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 8 Institute for Medical Education and Research 00:24:14 http://www.imeronline.com/podcast/media/220_8.m4v Fri, 12 Oct 2007 14:38:54 -0400 Fri, 12 Oct 2007 14:38:54 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 9 Institute for Medical Education and Research 00:04:19 http://www.imeronline.com/podcast/media/220_9.m4v Fri, 12 Oct 2007 14:43:07 -0400 Wed, 24 Oct 2007 10:44:20 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, cancer, treatment, oncology, renal cell carcinoma, rcc Episode 10 Institute for Medical Education and Research 00:10:39 http://www.imeronline.com/podcast/media/220_10.m4v Fri, 12 Oct 2007 14:44:26 -0400 Fri, 12 Oct 2007 14:44:26 -0400 The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology. IMER, cancer, treatment, oncology, renal cell carcinoma, rcc